RS49703B - Farmaceutske kompozicije koje sadrže vitamin d i kalcijum, njihovo dobijanje i upotreba - Google Patents

Farmaceutske kompozicije koje sadrže vitamin d i kalcijum, njihovo dobijanje i upotreba

Info

Publication number
RS49703B
RS49703B YUP-37/00A YU3700A RS49703B RS 49703 B RS49703 B RS 49703B YU 3700 A YU3700 A YU 3700A RS 49703 B RS49703 B RS 49703B
Authority
RS
Serbia
Prior art keywords
calcium
vitamin
preparation
pharmaceutical compositions
compositions containing
Prior art date
Application number
YUP-37/00A
Other languages
English (en)
Inventor
Maurizio Valleri
Alessandro Tosetti
Original Assignee
Menarini International Operations Luxembourg S.A.,
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Menarini International Operations Luxembourg S.A., filed Critical Menarini International Operations Luxembourg S.A.,
Publication of YU3700A publication Critical patent/YU3700A/sh
Publication of RS49703B publication Critical patent/RS49703B/sr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
    • A61K31/593—9,10-Secocholestane derivatives, e.g. cholecalciferol, i.e. vitamin D3
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1617—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
    • A61P3/14—Drugs for disorders of the metabolism for electrolyte homeostasis for calcium homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1617—Organic compounds, e.g. phospholipids, fats
    • A61K9/1623—Sugars or sugar alcohols, e.g. lactose; Derivatives thereof; Homeopathic globules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Rheumatology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Inorganic Chemistry (AREA)
  • Vascular Medicine (AREA)
  • Endocrinology (AREA)
  • Urology & Nephrology (AREA)
  • Nutrition Science (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Farmaceutska kompozicija koje sadrži kao aktivne sastojke Vitamin D zajedno sa kalcijumovom soli, naznačena time, što je sredstvo za vezivanje izabrano od propilen glikola, polietilen glikola molarne težine izmedju 300 i 1500, tečnog parafina ili silikonskog ulja, i što je Vitamin D prisutan u odnosu 1-2 g kalcijuma na 500-1000 I.U. Vitamina D, pri čemu takva farmaceutska kompozicija nije u obliku tečnog preparata spremnog za oralnu primenu. - Prijava sadrži još 15 patentnih zahteva.
YUP-37/00A 1997-07-30 1998-07-21 Farmaceutske kompozicije koje sadrže vitamin d i kalcijum, njihovo dobijanje i upotreba RS49703B (sr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT97FI000184A ITFI970184A1 (it) 1997-07-30 1997-07-30 Composizioni farmaceutiche contenenti vitamina d e calcio,loro preparazione ed uso terapeutico

Publications (2)

Publication Number Publication Date
YU3700A YU3700A (sh) 2002-11-15
RS49703B true RS49703B (sr) 2007-12-31

Family

ID=11352223

Family Applications (1)

Application Number Title Priority Date Filing Date
YUP-37/00A RS49703B (sr) 1997-07-30 1998-07-21 Farmaceutske kompozicije koje sadrže vitamin d i kalcijum, njihovo dobijanje i upotreba

Country Status (29)

Country Link
US (1) US7067154B1 (sr)
EP (1) EP0999843B1 (sr)
JP (1) JP4497496B2 (sr)
KR (1) KR100573421B1 (sr)
AT (1) ATE271387T1 (sr)
AU (1) AU8978198A (sr)
BG (1) BG65044B1 (sr)
BR (1) BR9810832B1 (sr)
CA (1) CA2299420C (sr)
CZ (1) CZ297670B6 (sr)
DE (1) DE69825164D1 (sr)
EA (1) EA002492B1 (sr)
EE (1) EE04046B1 (sr)
ES (1) ES2223135T3 (sr)
HK (1) HK1027751A1 (sr)
HU (1) HU226112B1 (sr)
ID (1) ID23504A (sr)
IL (1) IL134268A0 (sr)
IS (1) IS5359A (sr)
IT (1) ITFI970184A1 (sr)
NO (1) NO20000310L (sr)
PL (1) PL189295B1 (sr)
PT (1) PT999843E (sr)
RS (1) RS49703B (sr)
SI (1) SI0999843T1 (sr)
SK (1) SK284873B6 (sr)
TR (1) TR200000261T2 (sr)
UA (1) UA61968C2 (sr)
WO (1) WO1999006051A1 (sr)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040071789A1 (en) * 2002-02-14 2004-04-15 Baron John A Calcium supplementation to reduce prostate cancer risk
ES2192136B1 (es) * 2002-01-04 2005-03-16 Italfarmaco, S.A. Composiciones farmaceuticas para el tratamiento o prevencion de la osteoporosis.
ITFI20030194A1 (it) * 2003-07-17 2005-01-18 Menarini Int Operations Lu Sa Composizione farmaceutiche effervescenti contenenti
KR100898970B1 (ko) 2004-05-24 2009-05-25 니코메드 파마 에이에스 칼슘-함유 화합물 및 당알코올을 포함하는 입상체
CN1997362B (zh) 2004-06-01 2010-09-08 奈科明制药有限公司 包括含钙化合物作为活性物质的可咀嚼、可吮吸和可吞咽片剂
EP1845949B1 (en) 2005-02-03 2008-05-21 Nycomed Pharma AS Melt granulation of a composition containing a calcium-containing compound
CN103479582A (zh) 2005-02-03 2014-01-01 武田奈科明有限公司 制备含钙组合物的快速湿聚结方法
JP5303276B2 (ja) * 2005-10-12 2013-10-02 プロヴェンティヴ セラピュティックス リミテッド ライアビリティ カンパニー ２５−ヒドロキシビタミンｄ不足および欠乏を治療するための方法および製品
CN101365426B (zh) 2005-12-07 2012-08-08 奈科明制药有限公司 预先压实的含钙组合物
UA95093C2 (uk) * 2005-12-07 2011-07-11 Нікомед Фарма Ас Спосіб одержання кальцієвмісної сполуки
MXPA05014091A (es) * 2005-12-20 2007-06-20 Leopoldo De Jesus Espinosa Abdala Composiciones farmaceuticas que comprenden derivados de esteroides sinteticos, minerales y el metabolito activo de la vitamina d, 1,25(oh)2d3 (calcitriol) para la prevencion y tratamiento de la osteoporosis y el control de los sintomas de la menopaus
CA2835910C (en) * 2007-04-25 2016-06-28 Warner Chilcott Company, Llc Improved vitamin d content uniformity in pharmaceutical dosage forms
MX2011004744A (es) 2008-11-17 2011-05-30 Nycomed Pharma As Estabilidad mejorada de disolucion de tabletas de carbonato de calcio.
TR200900880A2 (tr) 2009-02-05 2010-08-23 Bi̇lgi̇ç Mahmut Tek bir dozaj formunda kombine edilen farmasötik bileşimler.
TR200900878A2 (tr) 2009-02-05 2010-08-23 Bi̇lgi̇ç Mahmut Tek bir dozaj formunda kombine edilen farmasötik formülasyonlar
TR200908237A2 (tr) 2009-11-02 2011-05-23 Bi̇lgi̇ç Mahmut Kalsiyum ve D vitamini içeren farmasötik bileşimler.
US20120015913A1 (en) 2010-07-15 2012-01-19 Delansorne Remi Formulations of 14-EPI-Analogues of Vitamin D
JP6554034B2 (ja) * 2013-08-09 2019-07-31 日東薬品工業株式会社 カルシウム剤
CN105166935B (zh) * 2015-09-01 2018-08-31 张伟 一种含有维生素d3的液体制剂及其制备方法
SG11202010792TA (en) 2018-05-02 2020-11-27 Ferring Bv Improved pharmaceutical formulations
KR102211287B1 (ko) * 2018-12-21 2021-02-03 (주)휴온스 비타민 d 또는 이의 유도체를 포함하는 안정성이 개선된 액상 제제
MX2023010739A (es) * 2021-03-12 2023-09-20 Nicoventures Trading Ltd Productos orales con sistema autoemulsificante.

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2073271A1 (en) * 1969-12-11 1971-10-01 Boivin Jean Calcium salt - vitamin d2 compn - for treatment of decalcification of
ZA813205B (en) * 1980-12-05 1983-03-30 Smith Kline French Lab Dosage units
DK8603837A (sr) * 1985-08-13 1987-02-14
US5624683A (en) * 1986-08-06 1997-04-29 Eisai Co., Ltd. Sustained-release multi-granule tablet
DE69124223T2 (de) * 1990-02-05 1997-04-30 Lifescience Corp Vitamine und mineralien enthaltende nahrungszusätze
EP0730862A1 (en) * 1990-05-16 1996-09-11 Zbigniew Walaszek Formulation containing glucaric acid for the prevention or treatment of non-cancerous cellular hyperproliferation and dietary supplement
RO113611B1 (ro) * 1990-08-03 1998-09-30 Asta Pharma Ag Preparate solide de ifosfamida, administrate oral si procedeu de obtinere
IL103224A (en) * 1992-09-18 1998-08-16 Teva Pharma Stabilized pharmaceutical compositions containing derivatives of vitamins d2 and d3
FR2724844B1 (fr) * 1994-09-23 1997-01-24 Innothera Lab Sa Association therapeutique vitamino-calcique, son procede d'obtention et son utilisation
IL115241A (en) * 1994-09-26 2000-08-31 American Cyanamid Co Calcium dietary supplement
FR2760639B1 (fr) * 1997-03-14 2000-09-22 Innothera Lab Sa Association therapeutique mineralo-vitaminique sous forme de preparation unitaire liquide buvable

Also Published As

Publication number Publication date
CA2299420C (en) 2009-04-21
IL134268A0 (en) 2001-04-30
ID23504A (id) 2000-04-27
NO20000310D0 (no) 2000-01-21
PL189295B1 (pl) 2005-07-29
CZ2000199A3 (cs) 2000-05-17
DE69825164D1 (de) 2004-08-26
BR9810832A (pt) 2000-07-25
SK284873B6 (sk) 2006-01-05
US7067154B1 (en) 2006-06-27
NO20000310L (no) 2000-01-21
EP0999843A1 (en) 2000-05-17
SK802000A3 (en) 2000-07-11
KR20010022319A (ko) 2001-03-15
ITFI970184A1 (it) 1999-01-30
CZ297670B6 (cs) 2007-02-28
ATE271387T1 (de) 2004-08-15
HUP0100539A2 (hu) 2001-08-28
SI0999843T1 (en) 2005-02-28
WO1999006051A1 (en) 1999-02-11
EP0999843B1 (en) 2004-07-21
BG65044B1 (bg) 2007-01-31
EE04046B1 (et) 2003-06-16
ES2223135T3 (es) 2005-02-16
HU226112B1 (en) 2008-04-28
HK1027751A1 (en) 2001-01-23
YU3700A (sh) 2002-11-15
JP2001511453A (ja) 2001-08-14
TR200000261T2 (tr) 2000-09-21
EA002492B1 (ru) 2002-06-27
EA200000181A1 (ru) 2000-10-30
BR9810832B1 (pt) 2010-11-16
CA2299420A1 (en) 1999-02-11
UA61968C2 (en) 2003-12-15
BG104057A (en) 2000-07-31
AU8978198A (en) 1999-02-22
PT999843E (pt) 2004-11-30
IS5359A (is) 2000-01-24
EE200000054A (et) 2000-10-16
KR100573421B1 (ko) 2006-04-26
JP4497496B2 (ja) 2010-07-07
PL338237A1 (en) 2000-10-09

Similar Documents

Publication Publication Date Title
RS49703B (sr) Farmaceutske kompozicije koje sadrže vitamin d i kalcijum, njihovo dobijanje i upotreba
HRP20010243B1 (en) Compositions containing diphosphonic acids
UA27899C2 (uk) Порошкова антибактеріальна композиція, що призначена для орального використання, яка містить гідратований цефтибутен
HUP9802448A2 (hu) Vérlemezke-aggregáció inhibitorvegyületei, ezek előállítása és alkalmazása és gyógyászati készítmények
MX9700223A (es) Composicion farmaceutica para la liberacion controlada de moguisteina en una suspension liquida.
NO20030897D0 (no) Fremgangsmåte for fremstilling av farmasöytiske sammensetninger for anvendelse med blöte gelatin formuleringer
KR890700125A (ko) 신규 벤즈이미다졸 유도체, 그 제조방법 및 이 화합물을 함유하는 제약 조성물
BR0015256A (pt) Composições farmacêuticas contendo uma droga de antibiótico de fluoroquinolona e uma goma de xantano
IT8521603A0 (it) Composizioni farmaceutiche contenenti come principi attivi flavanolignani e fosfolipidi.
NZ511085A (en) Oral pharmaceutical compositions containing buprenorphin
IL107838A0 (en) Compounds useful as cytokine release inhibitors and il-1 antagonists, their preparation and pharmaceutical compositions containing them
IT1272149B (it) Composizione farmeceutiche ad attivita' analgesica
MXPA03000430A (es) Nuevas arileteno-sulfonamidas.
MX9307203A (es) COMPUESTOS ESTEROIDALES DE ACIL-3-CARBOXI-3,5-DIENO-17Ó Y 17ß -SUBSTITUIDOS.
RS49608B (sr) Stabilizovane farmaceutske smeše na bazi hinupristina i dalfopristina i njihovo dobivanje
IT1186754B (it) Composizioni farmaceutiche e cosmetiche contenenti come ingrediente attivo diidrossi-1,8 fenil-10 antrone-9,e procedimento di preparazione dell'ingrediente attivo
FR2541114B1 (fr) Compositions pharmaceutiques antifongiques utilisables par voie orale contenant de l'omoconazole
FR2785191B1 (fr) Utilisation de gommes xanthanes pour la preparation de compositions pharmaceutiques
FR2567756B1 (fr) Nouvelles compositions pharmaceutiques contenant comme ingredient actif l'acetyl-10 triacetoxy-1,8,9 anthracene
BR9805026A (pt) Compostos contdndo tetrahidrolipstatina
ITMI951210A0 (it) Nuovi derivati dell'alfa-tocoferolo e composizioni farmaceutiche che li contengono quali principi attivi